There is growing evidence that some single-nucleotide polymorphisms (SNPs) of CR1 confer AD risk and are associated with Aβ accumulation (Lambert et al., 2009; Zhu et al., 2015, 2020). This evidence concerns the gene CR1 and Alzheimer disease.